Basics EyePoint Pharmaceuticals, Inc. Common Stock IPO Date: February 1, 2005 Sector: Healthcare Industry: Pharma Market Cap: $965.67M Activated in VL: True Average Daily Range Avg Daily Range: $0.26 | 3.78% Avg Daily Range (30 D): $0.33 | 2.99% Avg Daily Range (90 D): $0.32 | 3.61% Institutional Daily Volume Avg Daily Volume: .57M Avg Daily Volume (30 D): .55M Avg Daily Volume (90 D): .61M Trade Size Avg Trade Size (Sh.): 126 Avg Trade Size (Sh.) (30 D): 65 Avg Trade Size (Sh.) (90 D): 73 Institutional Trades Total Inst.Trades: 707 Avg Inst. Trade: $1.54M Avg Inst. Trade (30 D): $.82M Avg Inst. Trade (90 D): $1.03M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.5M Avg Closing Trade (30 D): $.78M Avg Closing Trade (90 D): $1M Avg Closing Volume: 121.45K     News Aug 26, 2025 @ 11:00 AM EyePoint Announces Participation at Upcoming Inves... Source: Eyepoint Pharmaceuticals, Inc. Jul 30, 2025 @ 11:00 AM EyePoint to Report Second Quarter 2025 Financial R... Source: Eyepoint Pharmaceuticals Jul 29, 2025 @ 11:00 AM EyePoint Completes Enrollment of Pivotal Phase 3 T... Source: Eyepoint Pharmaceuticals Jul 16, 2025 @ 11:00 AM EyePoint Reports Inducement Grants Under NASDAQ Li... Source: Eyepoint Pharmaceuticals, Inc. May 16, 2025 @ 11:00 AM EyePoint Pharmaceuticals Reports Inducement Grants... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-2.69 $-.85 $-.65 Diluted EPS $-2.69 $-.85 $-.65 Revenue $ 51.9M $ 5.33M $ 24.45M Gross Profit $ $ $ Net Income / Loss $ -175.38M $ -59.43M $ -45.2M Operating Income / Loss $ -189.05M $ -62.23M $ -48.84M Cost of Revenue $ $ $ Net Cash Flow $ -19.63M $ -14.02M $ -14.55M PE Ratio     Splits Dec 09, 2020:   1:10 Jun 11, 2008:   1:4